Oncotelic Therapeutics ($OTLC) Insider Trading & Smart Money Activity

Oncotelic Therapeutics, Inc. · Biotechnology · Latest filing Jun 24, 2026

Oncotelic Therapeutics, Inc. ($OTLC) has 6 insider trades on file. In the last 12 months on the open market, 2 insiders bought ($32.93K) and no insider sold, net +$32.93K.

Insider buyers (12 mo)
2
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$32.93K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

OTLC insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 6 · $32.93K 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All OTLC insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Vuong TrieuCHAIRMAN AND CEO Buy (Open-market buy) 115K sh $5.75K 0.0%0.0% Read
Insider Vuong TrieuCHAIRMAN AND CEO Buy (Open-market buy) 75K sh $3.75K -20.0%-40.0% Read
Insider Vuong TrieuCHAIRMAN AND CEO Buy (Open-market buy) 65K sh $3.25K -20.0%-20.0% Read
Insider Amit ShahCFO Buy (Open-market buy) 20K sh $1K -20.0%-20.0% —
Insider Vuong TrieuCHAIRMAN AND CEO Buy (Open-market buy) 239.76K sh $9.59K -20.0%-20.0% —
Insider Vuong TrieuCHAIRMAN AND CEO Buy (Open-market buy) 239.76K sh $9.59K -20.0%-20.0% —

1W / 1M / 6M = how OTLC moved from the trade or filing date.

Insider trading in OTLC: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Vuong Trieu CHAIRMAN AND CEO 5 +$31.93K Jun 24, 2026
Amit Shah CFO 1 +$1K Jun 22, 2026

Frequently asked questions

Are OTLC insiders buying or selling?

Over the last 12 months 2 insiders made 6 open-market purchases worth $32.93K and 0 insiders made 0 open-market sales worth $0, a net +$32.93K.

What is the latest insider trade in OTLC?

Vuong Trieu, CHAIRMAN AND CEO filed a buy (open-market buy) of 115K sh worth $5.75K on Jun 24, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text